Zentek (FRA:ZAY0) FCF Margin % : -11,054.55% (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Zentek FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Zentek's Free Cash Flow for the three months ended in Sep. 2024 was €-1.22 Mil. Zentek's Revenue for the three months ended in Sep. 2024 was €0.01 Mil. Therefore, Zentek's FCF Margin % for the quarter that ended in Sep. 2024 was -11,054.55%.

As of today, Zentek's current FCF Yield % is -4.14%.

The historical rank and industry rank for Zentek's FCF Margin % or its related term are showing as below:

FRA:ZAY0' s FCF Margin % Range Over the Past 10 Years
Min: -27906.67 Med: -20863.01 Max: -3522.06
Current: -17930.77

During the past 13 years, the highest FCF Margin % of Zentek was -3522.06%. The lowest was -27906.67%. And the median was -20863.01%.

FRA:ZAY0's FCF Margin % is ranked worse than
99.27% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -4.42 vs FRA:ZAY0: -17930.77

Zentek FCF Margin % Historical Data

The historical data trend for Zentek's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentek FCF Margin % Chart

Zentek Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

-3,520.08

-20,792.00

-28,450.00

Zentek Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-24,462.50	-16,600.00	-28,925.00	-32,033.33	-11,054.55

Competitive Comparison of Zentek's FCF Margin %

For the Medical Instruments & Supplies subindustry, Zentek's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zentek's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zentek's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Zentek's FCF Margin % falls into.

Zentek FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Zentek's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	-5.69	/	0.02
	=	-28,450.00 %

Zentek's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-1.216	/	0.011
	=	-11,054.55 %

Zentek FCF Margin % Related Terms

Thank you for viewing the detailed overview of Zentek's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zentek Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (FRA:ZAY0) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

ZTEK:USA ZAY:Germany ZEN:Canada

Address

24 Corporate Court, Guelph, ON, CAN, N1G 5G5

Website

https://www.zentek.com

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Zentek Headlines

No Headlines